TGFB1 and cancer: Our study revealed that elevated serum IL-6, TNF-α, and TGF-β and decreased IL-10 levels revealed that patients with ESCC and model mice demonstrated increased immune levels, and these inflammatory cytokines are considered important mediators associated with inflammation and cancer.